NCT02245568

Who might be able to join this trial:

• You must have already completed participation in one of three specific earlier TauRx research studies (TRx-237-005, TRx-237-008, or TRx-237-015) for dementia or probable Alzheimer's disease, including a 4-week follow-up visit at the end of that study
• Alternatively, you must have already completed participation up to Week 52 in a specific earlier TauRx study (TRx-237-007) for a condition called behavioural variant frontotemporal dementia (a type of brain condition affecting behaviour and personality)
• If you are a woman who could become pregnant, you must be willing to use reliable contraception or practice complete abstinence throughout the study
• You (or a legal representative acting on your behalf, if needed) must be able to read, understand, and sign a written consent form agreeing to take part
• You must have an adult caregiver who consents to be involved, can speak the language used at the study site, spends at least 1 hour a day with you at least 3 days a week, is willing to come with you to every study visit, and can confirm you are taking the study medication as directed
• You must be able to follow the study procedures throughout the trial

Who may not be able to join:

• People who have a history of difficulty swallowing
• People who are currently pregnant or breastfeeding
• People who have significant abnormal results from lab tests, heart monitoring, or scans, or who have developed a serious illness that the lead doctor believes makes the risks of joining the trial too high
• People who are currently in another clinical trial or plan to join one during this study
• In Germany specifically: people who are required to live in a full-time care or assisted living facility, or whose ability to freely choose to participate may be unduly influenced (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.